Showing 13,841 - 13,860 results of 14,473 for search '(( 50 ((ns decrease) OR (we decrease)) ) OR ( 5 ((wt decrease) OR (nn decrease)) ))', query time: 0.85s Refine Results
  1. 13841

    Table_2_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

    Published 2022
    “…Eligibility criteria: studies reporting detailed BM data with an adequate sample size (randomized clinical trials [RCTs]: N ≥50; non-RCTs: N ≥100) in patients with SCLC. We summarized the reported risk factors and performed meta-analysis to estimate the pooled hazard ratios (HR) if enough qualified data (i.e., two or more studies; the same study type; the same analysis method; and HRs retrievable) were available. …”
  2. 13842

    Table_7_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

    Published 2022
    “…Eligibility criteria: studies reporting detailed BM data with an adequate sample size (randomized clinical trials [RCTs]: N ≥50; non-RCTs: N ≥100) in patients with SCLC. We summarized the reported risk factors and performed meta-analysis to estimate the pooled hazard ratios (HR) if enough qualified data (i.e., two or more studies; the same study type; the same analysis method; and HRs retrievable) were available. …”
  3. 13843

    Table_1_Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis.DOCX by Mariapaola Marino (784475)

    Published 2020
    “…In patients’ sera, we titrated MuSK-specific IgG (MuSK-IgG) and MuSK-IgG4, along with total IgG and IgG4 levels. …”
  4. 13844

    Image_1_Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose.TIFF by Alessandra Mangia (626370)

    Published 2022
    “…Following the predictive model of protection by Khoury, we transformed the neutralizing titers in IU/ml and used a 54 IU/ml threshold to identify subjects with 50% protective immunity. …”
  5. 13845

    Table_1_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

    Published 2022
    “…Eligibility criteria: studies reporting detailed BM data with an adequate sample size (randomized clinical trials [RCTs]: N ≥50; non-RCTs: N ≥100) in patients with SCLC. We summarized the reported risk factors and performed meta-analysis to estimate the pooled hazard ratios (HR) if enough qualified data (i.e., two or more studies; the same study type; the same analysis method; and HRs retrievable) were available. …”
  6. 13846

    Table_5_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

    Published 2022
    “…Eligibility criteria: studies reporting detailed BM data with an adequate sample size (randomized clinical trials [RCTs]: N ≥50; non-RCTs: N ≥100) in patients with SCLC. We summarized the reported risk factors and performed meta-analysis to estimate the pooled hazard ratios (HR) if enough qualified data (i.e., two or more studies; the same study type; the same analysis method; and HRs retrievable) were available. …”
  7. 13847

    Table 2_Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b.docx by Tao Wang (12008)

    Published 2025
    “…Among these 26 patients, 50% (13/26) experienced reversion within 24 weeks, and 80.77% within 48 weeks; thereafter, the number of reversions gradually decreased. …”
  8. 13848

    Image_2_Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose.TIFF by Alessandra Mangia (626370)

    Published 2022
    “…Following the predictive model of protection by Khoury, we transformed the neutralizing titers in IU/ml and used a 54 IU/ml threshold to identify subjects with 50% protective immunity. …”
  9. 13849

    Table 1_Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b.docx by Tao Wang (12008)

    Published 2025
    “…Among these 26 patients, 50% (13/26) experienced reversion within 24 weeks, and 80.77% within 48 weeks; thereafter, the number of reversions gradually decreased. …”
  10. 13850

    Presentation_1_Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver F... by Sami Gharbia (5623040)

    Published 2018
    “…Sy-HPBCD was found to be the most potent anti-fibrotic complex. We demonstrated that Sy-HPBCD and Sy-RAMEB complexes decreased extracellular matrix accumulation by inhibiting HSC activation and diminished the oxidative damage. …”
  11. 13851

    DataSheet_7_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc... by Wenhao Xu (2302681)

    Published 2021
    “…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
  12. 13852

    DataSheet_6_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc... by Wenhao Xu (2302681)

    Published 2021
    “…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
  13. 13853

    Data_Sheet_1_Effect of breathing intervention in patients with COVID and healthcare workers.docx by Manjari Rain (10169170)

    Published 2022
    “…D-dimer was the primary outcome, which remained below 0.50 μg/ml (a cutoff value to define severity) in the COVID-positive yoga group (CYG) and decreased in the COVID-recovered yoga group (RYG) and the HCW yoga group (HYG) after intervention. …”
  14. 13854

    DataSheet_9_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc... by Wenhao Xu (2302681)

    Published 2021
    “…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
  15. 13855

    DataSheet_1_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc... by Wenhao Xu (2302681)

    Published 2021
    “…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
  16. 13856

    DataSheet_2_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc... by Wenhao Xu (2302681)

    Published 2021
    “…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
  17. 13857

    DataSheet_4_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc... by Wenhao Xu (2302681)

    Published 2021
    “…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
  18. 13858

    DataSheet_10_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Car... by Wenhao Xu (2302681)

    Published 2021
    “…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
  19. 13859

    DataSheet_8_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc... by Wenhao Xu (2302681)

    Published 2021
    “…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”
  20. 13860

    DataSheet_3_Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carc... by Wenhao Xu (2302681)

    Published 2021
    “…After RBCK1 expression was confirmed in ccRCC, we found a significantly decreased number of infiltrating CD4<sup>+</sup> T cells, CD4<sup>+</sup> FOXP3<sup>+</sup> Treg cells, M1 macrophages, and CD56<sup>bight/dim</sup> NK cells in the immune-cold RBCK1<sup>high</sup> group. …”